Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 1,122,903
- Share change
- +46,649
- Total reported value
- $258,567
- Price per share
- $0.23
- Number of holders
- 17
- Value change
- +$9,765
- Number of buys
- 3
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13D/G
13F
|
Company |
10%
|
6,127,662
|
$5,269,789 | $0 | 19 Mar 2025 | |
| Michael J. Fox |
3/4/5
|
Director |
—
mixed-class rows
|
1,148,800
mixed-class rows
|
$3,036,000 | — | 05 Jun 2024 | |
| Cameron Gray |
3/4/5
|
Director |
—
class O/S missing
|
687,049
|
$1,896,255 | — | 14 Jun 2022 | |
| Mark E. Strome |
13D/G
|
— |
5%
|
2,166,242
|
$1,862,968 | $0 | 14 Nov 2022 | |
| GC Wealth Management RIA, LLC |
13F
|
Company |
11%
|
4,631,644
|
$1,414,504 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.9%
|
3,014,034
|
$919,280 | — | 31 Dec 2025 | |
| Slate Path Capital LP |
13D/G
|
— |
1.4%
|
918,836
|
$790,199 | $0 | 31 Dec 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
5.1%
|
2,202,854
|
$672,752 | — | 31 Dec 2025 | |
| Anish Suri |
3/4/5
|
PRESIDENT AND CSO |
—
mixed-class rows
|
285,638
mixed-class rows
|
$374,361 | — | 05 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
803,291
|
$245,361 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
704,297
|
$215,092 | — | 31 Dec 2025 | |
| Daniel R. Passeri |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
614,578
mixed-class rows
|
$169,515 | — | 21 Mar 2025 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$146,134 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1%
|
449,162
|
$137,174 | — | 31 Dec 2025 | |
| Texas Capital Bank Wealth Management Services Inc |
13F
|
Company |
1%
|
440,670
|
$134,580 | — | 31 Dec 2025 | |
| Pasha Sarraf |
3/4/5
|
Director |
—
mixed-class rows
|
348,257
mixed-class rows
|
$97,675 | +$99,747 | 02 Jan 2026 | |
| ANGELES WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
310,000
|
$94,674 | — | 31 Dec 2025 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
257,225
|
$78,557 | — | 31 Dec 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.57%
|
246,556
|
$75,298 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.55%
|
238,354
|
$72,793 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.48%
|
207,569
|
$63,309 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.41%
|
179,353
|
$54,774 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.39%
|
168,829
|
$51,561 | — | 31 Dec 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.2%
|
85,937
|
$32,656 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.23%
|
100,957
|
$30,832 | — | 31 Dec 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.18%
|
79,500
|
$24,280 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.16%
|
69,793
|
$21,315 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
46,848
|
$14,288 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.11%
|
46,390
|
$14,167 | — | 31 Dec 2025 | |
| Sigma Planning Corp |
13F
|
Company |
0.09%
|
41,050
|
$12,537 | — | 31 Dec 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.05%
|
20,000
|
$6,108 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.05%
|
20,863
|
$6,000 | — | 31 Dec 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
20,000
|
$6,000 | — | 31 Dec 2025 | |
| PREVAIL INNOVATIVE WEALTH ADVISORS, LLC |
13F
|
Company |
0.04%
|
18,987
|
$5,799 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
18,594
|
$5,679 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
14,371
|
$4,389 | — | 31 Dec 2025 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.02%
|
10,000
|
$3,870 | — | 31 Dec 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.03%
|
10,929
|
$3,338 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,029
|
$1,841 | — | 31 Dec 2025 | |
| Gleason Group, Inc. |
13F
|
Company |
0.01%
|
6,000
|
$1,832 | — | 31 Dec 2025 | |
| New Millennium Group LLC |
13F
|
Company |
0.01%
|
5,750
|
$1,756 | — | 31 Dec 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
3,000
|
$916 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
2,563
|
$783 | — | 31 Dec 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
2,557
|
$780 | — | 31 Dec 2025 | |
| Golden State Wealth Management, LLC |
13F
|
Company |
0%
|
2,000
|
$611 | — | 31 Dec 2025 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
1,500
|
$458 | — | 31 Dec 2025 | |
| Physician Wealth Advisors, Inc. |
13F
|
Company |
0%
|
1,006
|
$308 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
680
|
$209 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
415
|
$127 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
400
|
$122 | — | 31 Dec 2025 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2026
As of 31 Mar 2026,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,122,903 shares.
The largest 10 holders included
VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, Robertson Stephens Wealth Management, LLC, ANGELES WEALTH MANAGEMENT, LLC, UBS Group AG, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, ADVISORTRUST PARTNERS, LLC, Sigma Planning Corp, GSA CAPITAL PARTNERS LLP, and Cambridge Investment Research Advisors, Inc..
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
48
Q1 2026 holders
17
Holder diff
-31
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.